State of AI is shaking markets!
Rating of Strong AI tech is essential
3 weeks before the USA President election, the Emtech AI Rating of startups able to make AGI in 5 years will be voted by top experts
Among August 5 Stock market’s meltdown reasons: LLMs that reached the tipping point, and investors discount future disillusions from unsustainable metrics. Their business model is too costly, for reaching break even in this century, and we see a lot of acquihire (hidden acquisitions) this Summer, after LLM companies are running our of money.
Elon Musk sues OpenAI again, alleging ‘deceit of Shakespearean proportions’ https://www.theguardian.com/technology/article/2024/aug/05/elon-musk-openai-lawsuit
SoftBank and OpenAi tanked markets: unsustainable LLM models and Emtech AI rating (linkedin.com)
AI still can produce the new reality of abundance, Peter Diamandis and Alvin Wang Graylin (speakers) are talking about (see by link above).
Blackrock just backed Groq that is now valued at $2.8B and this $640M round of funding will help Groq deploy 108,000 LPUs — their answer to NVIDIA GPUs — by Q2 2025. This startup is sustainable.
To help investors figure out who is who in terms of sustainable leadership, and is able to become the next Nvidia
Who is able to make Strong AGI in 5 years: top Emtech experts will vote, at Strong AI summit.
Long list of Emerging technologies and leaders
1.MemComputing — Memristive Computing
Non-von Neumann Architecture: Most computers today follow the von Neumann architecture. This model has memory (where data is stored) and processing (where calculations are done) as distinct units. Traditional computers separate memory and processing. This can lead to bottlenecks, as data needs to constantly shuttle back and forth between memory and the processor. MemComputing processors blur that line.
MemComputing is a San Diego-based startup with a truly unique approach to neuromorphic computing. Unlike the companies we’ve discussed so far, MemComputing leverages physics-based computing principles. Their technology centers around “memcomputing” processors designed for complex optimization problems.
2.Neuromorphic processors
BrainChip, headquartered in California, is a leader in neuromorphic computing. bringing brain-like efficiency to edge AI, and their established commercial partnerships. Their core product is the Akida neuromorphic processor, which is designed for low-power yet powerful edge AI.
3. AGI in healthtech
Hippocratic AI develops the safe artificial Health General Intelligence (HGI). They collaborate with Nvidia, developing task-specific Generative AI Healthcare Agents, powered by the company’s safety-focused LLM.
But the leader in this area is www.Verseon.com AI drug development unicorn, with personalized data heavy platform for healthspan, and Nobel prize winners in the Board
An emerging platform in this field is Accofrisc
The core is ARIA artificial intelligence based on aneural network trained on health monitoring data from over 2 million people.
Next part of Rating will be posted in next articles
Methodology of Emtech Rating.
Edward Musinski’s methodology is based on the ability to build (not only invent) a working AGI, able to make decisions to save lives or benefit humanity, to do health diagnostics and other use cases. He believes that AGI should have a beautiful purpose, and that purpose can be only benevolent. Otherwise AGI simply will not work.
The aim of the Emtech AI Rating is to demonstrate to top global funds, which will convene at Strong AI Summit, the ability of the the first joint panel of experts and AIs, to predict the success of startups.
This article will change your mind about the AI hype
Why is every big company investing in AI?
Because of the ultimate power that AGI can provide: influencing decisions of billions. All companies will continue to invest, being not able to tell the difference between AI technologies and the potential of startups to develop these technologies.
Technologies change a lot but human behavior. All want domination.
This is why the race for AGI domination is so fierce: AGI is the ultimate technology by power to change all markets.
History of Emtech Rating.
First Emtech rating was presented at WEF 4 years ago.
One of methods of evaluating AGI, in contrast to Turing test, is ARC.
Instead of drills on tests, ARC would lead to evaluating systems based on how efficient they are in the acquisition of skills. A solution to ARC, he hypothesizes, would be a system that has developed some “core knowledge priors,” broad information about the world, such as object permanence, but different from what people casually call “common sense.” The goal would be greater “generalization,” meaning, an ability for a system to succeed in held-out, hidden tasks that have been designed to be solvable with those priors.
Chollet describes ARC as a product of fifteen years of trying to “‘understand the mind.’” He was lately triggered, he writes, by the “narrow-mindedness” of pronouncements he’s heard made in the AI field, and an ahistoricity he observes in much recent work in reinforcement learning and such.
Two industries benefiting the most from AI development in LLM paradigm.
Energy:
AI is power-hungry. It’s predicted that AI will require 100% of the U.S. energy production by 2030. Renewable energy is the most daunting challenges and create abundance.
Biotech:
The decade ahead is the start of a healthcare revolution driven by converging tech like AI, gene therapies, and cellular medicines. I get excited by announcements like this one because they demonstrate that we still have large levers to pull to optimize healthspan. With IL-11 blockers already in human trials, we’re potentially on the cusp of a game-changing therapy that could redefine aging. Unlike previous studies, this breakthrough worked in both male and female mice, potentially adding 20 years to human lifespans — from 77.5 to 97 years. This is what we call a “bridge-two intervention,” where bridge-one is sleep, diet, exercise and not dying from something stupid.
Stay Informed: Stay abreast of the forefront of research in hormonal health, ensuring your practice is informed by the latest developments.
